JP Morgan Chase
ENTX icon

JP Morgan Chase’s Entera Bio ENTX Stock Holding History

JP Morgan Chase’s Portfolio ENTX Stock Details ENTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.15K Buy
+7,150
New +$10K ﹤0.01% 6818
2024
Q4 		– Sell
-2
Closed -$4 – 7466
2024
Q3 		$4 Buy
+2
New +$4 ﹤0.01% 7332
2024
Q2 		– Sell
-2
Closed -$3 – 7445
2024
Q1 		$3 Buy
+2
New +$2 ﹤0.01% 7291
2023
Q2 		– Sell
-1,868
Closed -$2K – 7025
2023
Q1 		$2K Buy
+1,868
New +$1.87K ﹤0.01% 6415
2022
Q1 		– Sell
-2
Closed – – 6698
2021
Q4 		$0 Hold
2
– – ﹤0.01% 6727
2021
Q3 		$0 Buy
+2
New +$10 ﹤0.01% 6555

Other funds holding ENTX

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
SFCM
Seven Fleet Capital Management Mountain View, California $318M AUM
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $14.2B AUM 37.17% 1-Year Est. Return
SEIA
Signature Estate & Investment Advisors Los Angeles, California $5.56B AUM 26.66% 1-Year Est. Return

JP Morgan Chase's ENTX Position: Q1 2026 in Review

JP Morgan Chase opened a new position in Entera Bio (ENTX) in Q1 2026: 7,150 shares worth $7.15K. The stake represents ﹤0.01% of the portfolio and ranks #6818 among its holdings. This is a return to the name: JP Morgan Chase previously reported a position in ENTX as recently as Q3 2024.

JP Morgan Chase first reported a position in ENTX in Q3 2021 and has held it in 6 quarters since. 26 funds tracked by Wall St. Rank hold ENTX as of Q1 2026.

  • JP Morgan Chase held 7,150 shares of Entera Bio worth $7.15K as of Q1 2026.
  • Entera Bio was a new JP Morgan Chase position in Q1 2026.
  • Entera Bio made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #6818 holding.
  • JP Morgan Chase first reported a position in Entera Bio in Q3 2021 and has held it in 6 quarters since.
  • 26 funds tracked by Wall St. Rank held Entera Bio as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.